Evidence map›Paper›PMID 28119130›Full record

ArticleHeart rhythm2017

No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction.

Alanna M Chamberlain, Bernard J Gersh, Alvaro Alonso, Stephen L Kopecky, Jill M Killian, Susan A Weston, Véronique L Roger

Abstract readMulticenter Study
In one paragraph

Article in Heart rhythm, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Multimorbidity in Atrial Fibrillation: Impact on Outcomes.Journal of the American Heart Association · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Alanna M ChamberlainDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. Electronic address: chamberlain.alanna@mayo.edu.
Bernard J GershDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Alvaro AlonsoDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.
Stephen L KopeckyDepartment of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Jill M KillianDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Susan A WestonDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Véronique L RogerDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Mayo Clinic · USMayo Clinic in Florida · USEmory University · US

Funding

Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
NIA NIH HHS R01 AG034676
6 · The paper itself

Abstract

backgroundPatients with atrial fibrillation (AF) experience an increased risk of heart failure (HF). However, data are lacking on current trends in the risk of HF after AF.

objectiveThe purpose of this study was to describe the temporal trends in HF occurrence after AF in a community cohort of patients with incident AF from 2000 to 2013.

methodsCox regression was used to examine the association of year of AF diagnosis with HF and the predictors of developing HF after AF.

resultsAmong 3491 AF patients without prior HF, 750 (21%) developed incident HF over mean follow-up of 3.7 years. Among those with an echocardiogram, 422 (61%) had HF with preserved ejection fraction (HFpEF), and 270 (39%) had HF with reduced ejection fraction (HFrEF). After adjusting for demographics and comorbidities, the risk of developing HF did not change over time (hazard ratio [HR] (95% confidence interval [CI]) per year of AF diagnosis: 1.01 (0.98-1.03) overall; 1.00 (0.98-1.03) for HFpEF; 1.00 (0.96-1.03) for HFrEF). Increasing age, obesity, smoking, diabetes, chronic pulmonary disease, and renal disease were predictors of developing HF. Compared to the Olmsted County, Minnesota, population, a substantial excess risk of developing HF was observed after AF diagnosis [standardized morbidity ratio (95% CI): 9.60 (7.44-12.19), 2.13 (1.56-2.84), and 1.70 (1.34-2.14) at 90 days, 1 year, and 3 years after diagnosis].

conclusionIn the community, HF is a frequent adverse outcome among patients with AF, and HFpEF is more common than HFrEF. The rates of HF after AF have not declined, thus highlighting the importance of continued efforts to improve outcomes in AF.

Indexed as

AgedAtrial FibrillationEchocardiographyFemaleFollow-Up StudiesHeart FailureHumansMaleMinnesotaMorbidityRetrospective StudiesRisk FactorsStroke VolumeSurvival RateTime FactorsAtrial fibrillationAtrial flutterEpidemiologyHeart failureOutcomes

Identifiers

PMID28119130
PMCPMC5440203
OpenAlexW2575125268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.